2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Conditions
Breast Neoplasms
542
Neoplasms
381
Carcinoma, Non-Small-Cell Lung
323
Colorectal Neoplasms
296
Lung Neoplasms
237
Prostatic Neoplasms
220
Carcinoma, Hepatocellular
212
Stomach Neoplasms
155
Pancreatic Neoplasms
155
Leukemia, Myeloid, Acute
141
Uterine Cervical Neoplasms
132
Multiple Myeloma
130
Recurrence
119
Rectal Neoplasms
114
Ovarian Neoplasms
109
Neoplasm Metastasis
105
Squamous Cell Carcinoma of Head and Neck
98
Head and Neck Neoplasms
90
Triple Negative Breast Neoplasms
86
Esophageal Neoplasms
84
Glioblastoma
81
Endometrial Neoplasms
81
Small Cell Lung Carcinoma
79
Colonic Neoplasms
78
Brain Neoplasms
77
Melanoma
70
Precursor Cell Lymphoblastic Leukemia-Lymphoma
65
Hematologic Neoplasms
65
Glioma
61
Disease
60
Interventions
pembrolizumab
1
enfortumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Advanced Bladder Cancer
×
Clear all
NCT07346053
2026-01-16
Chrono-EVP
British Columbia Cancer Agency
Phase 3
Not yet recruiting
224 enrolled
NCT07204496
2025-10-02
γδ-T-BLADDER
Shanghai 10th People's Hospital
Not yet recruiting
20 enrolled